Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
8,366 results
  1. Genetics of Breast and Gynecologic Cancers (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65767
    ... the influence of other patient characteristics (e.g., age, gender, smoking status, medication use) on the ability of the biomarker to discriminate between those with and without preclinical disease. Phase 4 — Prospective screening studies Determine the operating characteristics ...
  2. Appendices - Fever in under 5s: assessment and initial management - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK552088
    ... Yusuke, Inuzuka, Ryo, Harita, Yutaka et al. (2013) Age-related differences in the course of the acute phase symptoms of Kawasaki disease. The Pediatric infectious disease journal 32(9): e365– ...
  3. Childhood Hodgkin Lymphoma Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65726
    ... After Initial Treatment With Autologous HCT In a phase II study, patients (median age, 26.5 years) who had relapsed or refractory disease after autologous HCT received brentuximab vedotin, with an ...
  4. NLM Digital Collections - Targeted immune modulators for rheumatoid arthritis : effectiveness and value : evidence ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, April 7, 2017
    resource.nlm.nih.gov/101723892
    ... PBO + cDMARD 18-75 years with adult Mean age, yrs (SD) the Rheumatic Company placebo-controlled countries: USA, (n=98) onset RA for ≥6months 1) 49 (12) Diseases 2015211 phase IIb Mexico, India, 2) 1mg BAR + and <15 ...
  5. pdfNLM Technical Bulletin, no.243-245 
    https://www.nlm.nih.gov/.../nlmarchives/techbull/243-245-1989.pdf
    ... NUMBERS VERSION NUMBER & DATE PROTOCOL CHAIRS GENERAL DESCRIPTION PHASE DISEASES STUDIED DISEASE STATUS PROTOCOL DETAILS INPATIENT/OUTPATIENT OPEN/CLOSED INDICATOR PATIENT INCLUSION CRITERIA PATIENT INCLUSION AGE PATIENT INCLUSION SEX OTHER PATIENT INCLUSION CRITERIA PATIENT ...
  6. NLM Digital Collections - Eye pathology lectures of Dr. Terry; notes taken and prepared by Virginia Spurrier 
    Publication: Produced: 1937
    resource.nlm.nih.gov/101265633
    ... bo on the con- stant outlook for this disease in all of its phases and at all ages. Glaucoma, the symptom complex commonly defined as abnormally ...
  7. Results - Comparative Effectiveness Review Methods: Clinical Heterogeneity - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK53317
    ... Most EPC authors considered demographic variables such as age, sex, race, and ... the protocol development phase (a priori); several consult with experts in the ...
  8. NLM Digital Collections - A text-book on diseases of the eye 
    Publication: New York : William Wood & Company, 1890
    resource.nlm.nih.gov/68010310R
    ... and will select the means suited to the age, health, and surroundings of the patient and the peculiar phase of the disease Avhether secondary or tertiary. Inunction of blue ointment ...
  9. NLM Digital Collections - Abstracts of orthopaedic surgery for 1948 (1950) 
    Publication: Washington, D.C. : Office of the Surgeon General, Department of the Army, 1951-1957
    resource.nlm.nih.gov/59830160RX3
    ... that these are all phases of the same disease. Vhat determines the phase is unknown unless it is the age of the patient at onset. WMTHOLD and HADDERS ( ...
  10. Osteosarcoma and Malignant Fibrous Histiocytoma of Bone Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK65736
    ... EFS for 96 patients with osteosarcoma and measurable disease was 12% at 4 ... ethnicity. One additional phase II trial with a different study design was ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last